Isis Pharmaceuticals Inc Insider Profile
4 Followers
Isis Pharmaceuticals Inc, former Ten Percent Owner at Regulus, holds 77.09M shares in Akcea Therapeutics (Ticker: AKCA), holds 5.17M shares in Regulus (Ticker: RGLS).
Isis Pharmaceuticals Inc's Trading History
| AKCAAkcea Therapeutics | Dec 19, 2019 | ― | Uninformative Buy | ― | $1.40B | |
| RGLSRegulus | Jul 17, 2015 | ― | Informative Sell | 3.63M | $42.21M |
You May Also Like
Isis Pharmaceuticals Inc insider profile FAQ
What is the percentage of profitable transactions made by Isis Pharmaceuticals Inc?
The percentage of profitable transactions made by Isis Pharmaceuticals Inc is 100%.
What is the average return per transaction made by Isis Pharmaceuticals Inc?
The average return per transaction made by Isis Pharmaceuticals Inc is 50.20%.
What stocks does Isis Pharmaceuticals Inc hold?
Isis Pharmaceuticals Inc holds: RGLS, AKCA stocks.
What was Isis Pharmaceuticals Inc's most profitable transaction?
Isis Pharmaceuticals Inc’s most profitable transaction was an Informative Sell of RGLS stock on July 2, 2015. The return on the trade was 68.50%.
What is Isis Pharmaceuticals Inc's role in Regulus?
Isis Pharmaceuticals Inc's role in Regulus is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
